Comparative effect of cilnidipine and quinapril on left ventricular mass in mild essential hypertension

Drugs under Experimental and Clinical Research

Volumn 29, Issue 3, 2003, Pages 117-123

  Sakata, K ^a   Yoshida, H ^b   Tamekiyo, H ^b   Obayashi, K ^b   Nawada, R ^b   Doi, O ^b   Mori, N ^b  

^a SHIZUOKA CANCER CENTER   (Japan)

^b SHIZUOKA GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; CILNIDIPINE; QUINAPRIL; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; DIHYDROPYRIDINE DERIVATIVE; RADIOACTIVE IODINE; TETRAHYDROISOQUINOLINE DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; COMPARATIVE STUDY; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; SCINTISCANNING; TIME;

3-IODOBENZYLGUANIDINE; ADULT; AGED; DIHYDROPYRIDINES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INJECTIONS, INTRAVENOUS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; TETRAHYDROISOQUINOLINES; TIME FACTORS;

EID: 0345528128     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N. Engl. J. Med., 322, 1561, 1990.
2. Koren M.J., Devereux R.B., Casale P.N., Savage D.D., Laragh J.H. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann. Intern. Med., 114, 345, 1991.
3. Verdecchia P., Schillaci G., Borgioni C., et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation, 97, 48, 1998.
4. Mancia G., Grassi G., Giannattasio C., Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension, 34, 724, 1999.
5. Sakata K., Shirotani M., Yoshida H., Kurata C. Cardiac sympathetic nervous system in essential hypertension assessed by iodine-123-metaiodobenzy/guanidine images. J. Nucl. Med., 40, 6, 1999.
6. Watanabe K., Sekiya M., Tsuruoka T., et al. Relationship between insulin resistance and cardiac sympathetic nervous function in essential hypertension. J. Hypertens., 17, 1161, 1999.
7. Schmieder R.E., Langenfield M.R.W., Friedrich A., Schobel H.P., Gatzka C.D., Weihprecht H. Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension. Circulation, 94, 1304, 1996.
8. Schmieder R.E., Martus P., Kingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA, 275, 1507, 1996.
9. Weinstein M., Hilewitz H., Rogel S. The effect of single-dose methyldopa and diuretic on BP and left ventricular mass. Arch. Intern. Med., 144, 1629, 1984.
10. Huting J., Mitrovic V., Thormann J., Bahavar H., Schlepper M. Left ventricular mass and diastolic function in patients with essential hypertension under long-term clanidine monotherapy. Clin. Cardiol., 14, 134, 1991.
11. Sakata K., Shirotani M., Yoshida H., et al. The effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension. Hypertension, 88, 1447, 1999.
12. Uneyama H., Uchida H., Yoshimoto R., Ueno S., Inoue K., Akaike N. Effects of a novel antihypertensive drug, cilnidipine, on catecholamine secretion from differentiated PC12 cells. Hypertension, 31, 1195, 1998.
13. Ishii M., Matsuoka H., Imamura O., et al. Efficacy and safety of FRC-8653 (cilnidipine) inpatients with essential hypertension: A-dose-finding study in monotherapy and combined therapy with beta-blocking agents or thiazide diuretics (in Japanese). Jpn. Pharmacol. Ther., 21, 91, 1993.
14. Guidelines Sub-Committee. Guidelines for the management of mild hypertension: Memorandum from a WHO/ISH Meeting. J. Hypertens., 7, 689, 1989.
15. Shane D.J., Demur A., Chisels J., Weyman A. The committee on M-mode Standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography. Circulation, 58, 1072, 1978.
16. Wikstrand J. Calculation of left ventricular mass in man - a comment. J. Hypertens., 15, 811, 1997.
17. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J. Am. Soc. Echocardiogr., 2, 358, 1989.
18. Devereux R.B., Alonso D.R., Lutas E.M., et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am. J. Cardiol., 57, 450, 1986.
19. Gottdiener J.S., Reda D.J., Massie B.M., Materson B.J., Williams D.W., Anderson R.J. for the VA Cooperative study group on antihypertensive agents. Effects of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension. Comparison of six antihypertensive agents. The department of Veterans Affairs Cooperative study group on antihypertensive agents. Circulation, 95, 2007, 1997.
20. Diez J., Laviades C. Insulin-like growth factor-1 and cardiac mass in essential hypertension: Comparative effects of captopril, lisinopril and quinapril. J. Hypertens., 12, 31, 1994.
21. Hattori N., Schwaiger M. Metaiodobenzylguanidine scintigraphy of the heart: What have we learnt clinically? Eur. J. Nucl. Med., 27, 1, 2000.
22. Cody R.J. The sympathetic nervous system and the renin-angiotensin-aldosterone system in cardiovascular disease. Am. J. Cardiol., 80, 9, 1997.
23. Onose Y., Oki T., Yamada H., et al. Effects of cilnidipine on left ventricular diastolic function in hypertensive patients as assessed by pulse Doppler echocardiography and pulse tissue Doppler imaging. Jpn. Cir. J., 65, 305, 2001